BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

April 30, 2011

Conditions
Acne Vulgaris
Interventions
DRUG

BLI1100

BLI110 topical cream

DRUG

Vehicle cream

Vehicle topical cream

Trial Locations (20)

23507

Virginia Clinical Research, Norfolk

24501

The Education and Research Foundation, Lynchburg

30022

Atlanta Dermatology, Vein and Research Center, Alpharetta

30327

Peachtree Dermatology Associates Research Center, Atlanta

32174

Ameriderm Research, Ormond Beach

32204

North Florida Dermatology Associates, Jacksonville

46168

The Indiana Clinical Trials Center, Plainfield

46617

The South Bend Clinic, South Bend

55432

Minnesota Clinical Study Center, Fridley

77802

DiscoveResearch, Bryan

78229

Progressive Clinical Research, San Antonio

80220

Horizons Clinical Research Center, Denver

83686

Northwest Clinical Trials, Nampa

84124

Dermatology Research Center, Salt Lake City

87106

Academic Dermatology Associates, Albuquerque

90045

Dermatology Research Associates, Los Angeles

92056

Dermatology Specialists, Oceanside

94538

Center for Dermatology Clincal Research, Fremont

99204

Premier Clinical Research, Spokane

02919

Clinical Partners, Johnston

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY